Vanguard Capital Management
VIVS

Vanguard Capital Management’s VivoSim Labs VIVS Stock Holding History

Vanguard Capital Management’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4K Hold
15,371
– – ﹤0.01% 4022
2026
Q1 		$22K Buy
+15,371
New +$30.1K ﹤0.01% 3975

Other funds holding VIVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.81B AUM 32.31% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Vanguard Capital Management's VIVS Position: Q2 2026 in Review

Vanguard Capital Management held its VivoSim Labs (VIVS) position steady in Q2 2026 at 15,371 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4022.

Vanguard Capital Management first reported a position in VIVS in Q1 2026 and has held it in 2 quarters since. The position peaked at $22K in Q1 2026. 26 funds tracked by Wall St. Rank hold VIVS as of Q2 2026.

  • Vanguard Capital Management held 15,371 shares of VivoSim Labs worth $16.4K as of Q2 2026.
  • Vanguard Capital Management left its VivoSim Labs share count unchanged in Q2 2026.
  • VivoSim Labs made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #4022 holding.
  • Vanguard Capital Management first reported a position in VivoSim Labs in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's VivoSim Labs position peaked at $22K in Q1 2026.
  • 26 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.